Cargando…
Optical control of pain in vivo with a photoactive mGlu(5) receptor negative allosteric modulator
Light-operated drugs constitute a major target in drug discovery, since they may provide spatiotemporal resolution for the treatment of complex diseases (i.e. chronic pain). JF-NP-26 is an inactive photocaged derivative of the metabotropic glutamate type 5 (mGlu(5)) receptor negative allosteric modu...
Autores principales: | Font, Joan, López-Cano, Marc, Notartomaso, Serena, Scarselli, Pamela, Di Pietro, Paola, Bresolí-Obach, Roger, Battaglia, Giuseppe, Malhaire, Fanny, Rovira, Xavier, Catena, Juanlo, Giraldo, Jesús, Pin, Jean-Philippe, Fernández-Dueñas, Víctor, Goudet, Cyril, Nonell, Santi, Nicoletti, Ferdinando, Llebaria, Amadeu, Ciruela, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388536/ https://www.ncbi.nlm.nih.gov/pubmed/28395733 http://dx.doi.org/10.7554/eLife.23545 |
Ejemplares similares
-
Correction: Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator
por: Font, Joan, et al.
Publicado: (2018) -
Shining Light on an mGlu5 Photoswitchable NAM: A Theoretical Perspective
por: Dalton, James A.R., et al.
Publicado: (2016) -
mGlu1 Receptors Monopolize the Synaptic Control of Cerebellar Purkinje Cells by Epigenetically Down-Regulating mGlu5 Receptors
por: Notartomaso, Serena, et al.
Publicado: (2018) -
Control of Theta Oscillatory Activity Underlying Fear Expression by mGlu(5) Receptors
por: Matulewicz, Pawel, et al.
Publicado: (2022) -
A Light-Controlled Allosteric Modulator Unveils a Role for mGlu(4) Receptors During Early Stages of Ischemia in the Rodent Cerebellar Cortex
por: Bossi, Simon, et al.
Publicado: (2018)